Showing results (281-290 of 969) with videos related to
Sort By:
Pageof 97
Journal of Medical Case Reports|June 28, 2017
Adult cancer-related hemophagocytic lymphohistiocytosis - a challenging diagnosis: a case reportMichael A Hust, Boris R A Blechacz, Diana L Bonilla, et al.Blood Cancer Journal|October 31, 2020
New directions for emerging therapies in acute myeloid leukemia: the next chapterNaval Daver, Andrew H Wei, Daniel A Pollyea, et al.Haematologica|May 19, 2018
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trialWeiguo Zhang, Charlie Ly, Jo Ishizawa, et al.Haematologica|October 2, 2025
Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitorNicholas J Short, Sanam Loghavi, Musa Yilmaz, et al.American Journal of Hematology|July 29, 2023
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failureSamuel Urrutia, Kelly S Chien, Ziyi Li, et al.American Journal of Hematology|January 5, 2017
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantationSameh Gaballa, Rima Saliba, Betul Oran, et al.American Journal of Hematology|January 12, 2017
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agentsElias Jabbour, Paolo Strati, Monica Cabrero, et al.Cancers|November 27, 2024
Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center ExperienceDavid McCall, Shaikha Alqahtani, Moriah Budak, et al.American Journal of Hematology|April 26, 2021
Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemiaTapan M Kadia, Farhad Ravandi, Gautam Borthakur, et al.Current Hematologic Malignancy Reports|June 11, 2011
Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome-positive acute lymphoblastic leukemiaMichael S Mathisen, Susan O'Brien, Deborah Thomas, et al.Pageof 97